Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5y4tl | — |
Reconstitution error/administered the liquid portion only of Shingrix; Reconstitution error/administered the liquid portion only of Shingrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number 5y4tl, expiry date 31-JAN-2027) for prophylaxis. On 19-MAR-2025, the patient received Shingrix. On 19-MAR-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered (Verbatim: Reconstitution error/administered the liquid portion only of Shingrix) and inappropriate preparation of medication (Verbatim: Reconstitution error/administered the liquid portion only of Shingrix). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date: 24-MAR-2025 Lead Medical Assistant called to report that one of the office nurses administered the liquid portion only of Shingrix on March 19th 2025 which led to Inappropriate dose of vaccine administered and Inappropriate preparation of medication. The reporter asked when the complete dose should be repeated.